Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-31 to 2025-02-03
Current total value of award: $2284.25
Description: 4567113082!QUILLIVANT XR ORAL SUSP 120ML 5MG/ML